[{"Assets_0_Q1_USD":1135584000.0,"CIK":"1706431","CommonStockSharesConverted_0_Q1_shares":129891856.0,"CommonStockSharesOutstanding_0_Q1_shares":129891856.0,"Country":"United States","EarningsPerShareBasic_1_Q1_USD":-1.32,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"3076942595.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":-89529000.0,"NetIncomeLossConverted_1_Q1_USD":-168911000.0,"OfficialName":"Vir Biotechnology Inc. Common Stock","RevenuesConverted_1_Q1_USD":1976000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquity_0_Q1_USD":650951000.0,"Ticker":"VIR","filed":"20210506","footnote":"nan","form":"10-Q","fp":"Q1","fy":"2021.0","name":"VIR BIOTECHNOLOGY, INC.","period":"20210331","qtrs":"1","uom":"USD"}]